Cambridge Investment Research Advisors’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,104
| Closed | -$129K | – | 3471 |
|
|
2024
Q3 | $129K | Buy |
41,104
+104
| +0.3% | +$326 | ﹤0.01% | 3228 |
|
|
2024
Q2 | $91K | Hold |
41,000
| – | – | ﹤0.01% | 3163 |
|
|
2024
Q1 | $128K | Buy |
41,000
+1,000
| +3% | +$3.12K | ﹤0.01% | 3116 |
|
|
2023
Q4 | $155K | Sell |
40,000
-100
| -0.2% | -$388 | ﹤0.01% | 2962 |
|
|
2023
Q3 | $131K | Hold |
40,100
| – | – | ﹤0.01% | 2921 |
|
|
2023
Q2 | $128K | Hold |
40,100
| – | – | ﹤0.01% | 2963 |
|
|
2023
Q1 | $172K | Hold |
40,100
| – | – | ﹤0.01% | 2869 |
|
|
2022
Q4 | $170K | Buy |
40,100
+25,100
| +167% | +$106K | ﹤0.01% | 2801 |
|
|
2022
Q3 | $74K | Buy |
+15,000
| New | +$74K | ﹤0.01% | 2898 |
|